Innovate Biopharmaceuticals
Raleigh
About Innovate Biopharmaceuticals
Innovate, a privately held clinical stage biotechnology company, is focused on developing novel gastroenterology medicines. Their pipeline includes drug candidates for Celiac Disease and for mild to moderate ulcerative colitis, along with Secretin which improves pancreatic duct visualization in MRCP procedures. The Company is led by a strong management team with extensive business and regulatory experience. Innovate has all global rights to the products which are backed by more than 150 patents in the US, EU, and Japan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $32.2M
- Funding stage: M&A
- Last round: Post-IPO Equity (Apr 2019)
- Ticker: nasdaq:INNT
- Website: innovatebiopharma.comindex.html
- Phone: +1 9192751933
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/innovate-biopharmaceuticals-194795 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.